Abstract: The present invention provides a therapeutic agent or a prophylactic agent of dementia containing xanthine oxidase inhibitor such as a compound represented in formula (I), (II), (III) or (IV), or a pharmaceutically acceptable salt thereof as an active ingredient.
Type:
Grant
Filed:
February 17, 2017
Date of Patent:
May 31, 2022
Assignees:
NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY, Tejin Pharma Limited